12:00 AM
 | 
Jun 28, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Motavizumab regulatory update

AstraZeneca said FDA issued a new PDUFA date of Aug. 27 for a BLA from the company's MedImmune...

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >